|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007257,
umls-concept:C0013216,
umls-concept:C0023972,
umls-concept:C0033223,
umls-concept:C0038952,
umls-concept:C0042679,
umls-concept:C0070167,
umls-concept:C0085533,
umls-concept:C0282443,
umls-concept:C0334579,
umls-concept:C0442711,
umls-concept:C1514695,
umls-concept:C1514923,
umls-concept:C1552617
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2000-1-18
|
|
pubmed:abstractText |
To determine any differences in outcome for patients with anaplastic astrocytoma (AA) treated with adjuvant carmustine (BCNU) versus procarbazine, lomustine, and vincristine (PCV) chemotherapy.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3389-95
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10550132-Adult,
pubmed-meshheading:10550132-Aged,
pubmed-meshheading:10550132-Analysis of Variance,
pubmed-meshheading:10550132-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10550132-Astrocytoma,
pubmed-meshheading:10550132-Carmustine,
pubmed-meshheading:10550132-Combined Modality Therapy,
pubmed-meshheading:10550132-Female,
pubmed-meshheading:10550132-Humans,
pubmed-meshheading:10550132-Karnofsky Performance Status,
pubmed-meshheading:10550132-Lomustine,
pubmed-meshheading:10550132-Male,
pubmed-meshheading:10550132-Middle Aged,
pubmed-meshheading:10550132-Procarbazine,
pubmed-meshheading:10550132-Randomized Controlled Trials as Topic,
pubmed-meshheading:10550132-Retrospective Studies,
pubmed-meshheading:10550132-Survival Analysis,
pubmed-meshheading:10550132-Vincristine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
|
|
pubmed:affiliation |
Department of Neurosurgery, University of California-San Francisco, San Francisco, CA 94143-0372, USA. pradosm@neuro.ucsf.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|
